Latest filing published 22 Dec 2020 for Moberg Pharma AB, €5,113.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mattias Klintemar: trading record in brief
Mattias Klintemar discloses dealings in Moberg Pharma AB to Finansinspektionen. Between 9 March 2018 and 21 December 2020, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €15k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2020: 1 purchase and no sales on the market.
Most recently, on 22 December 2020, the filings show an open-market purchase worth €5,113 in Moberg Pharma AB. Most trades are made public on the day they happen. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mattias Klintemar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ SEK 6.4714.3% of flowBTU (betald tecknad unit)ISIN SE0015243761FI:csv-06ab3ed9aa9bf6e9054fCanonical exit: 21 Mar 2021 (T+90)
- 7,000 shares@ SEK 46.5085.7% of flowInlösenaktieISIN SE0013121365FI:csv-d0c4929c6132bc785210
- 4,000 shares@ SEK 23.90100.0% of flowFI:csv-686a5c4ab238501870c8Canonical exit: 7 Jun 2018 (T+90)
3 of 3 declarations